Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
Press Releases
Events
Tigermed Insights
Resource Library
Cloud Classroom
Sustainability & ESG Report
ESG Management
Corporate Responsibility
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Decentralized Clinical Trials (DCTs)
Site Management (SMO)
Subject Recruitment
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
Press Releases
A brand new start for Tigermed with new official website and new email domain!
May 08, 2020
May 8, 2020
After several months of work and dedication, we are thrilled to officially announce that Tigermed new website is now Live! We invite you to visit us at www.tigermedgrp.com.
Meanwhile, Tigermed corporate email domain name will be changed from “@tigermed.net” to “@tigermedgrp.com” with effect from May 6, 2020.
With objective of creating a more efficient communication between our global customers and Tigermed research platforms, and deliver our commitment with an integrated image of “One Group One Tigermed”, our corporate email domain name will be changed from “@tigermed.net” to “@tigermedgrp.com”.
Here tigermedgrp represents Tigermed Group, which embodies our global and integration strategy. Even after May 6, 2020, sufficient transition period for old email will be catered to ensure smooth migration and communications.
We have adopted a brand new design for Tigermed official website, the overall style is more simple and atmospheric, with a sense of both technology and human care, and a full screen interface.
With a new structure display, our website was re-organized in service category for customer-oriented and user friendly. All content is bilingual, with simple mouse scrolling and navigation bar menu, you can have a clear, complete and detailed understanding of the corporate overview, therapeutic areas, clinical trial solutions, professional capabilities, project experience, as well as investor and contact information.
We also create a special section “Tigermed Insight” to share our latest information, blogs and industry insights on clinical research. we believe knowledge needs to be shared to further develop clinical programs, increase market access, and to meet unmet patient needs.
You are always invited to request additional information or suggest a topic you would like to learn more about. Please use the contact page to reach us for any requests. We also invite you to connect with us on LinkedIn, Twitter, Facebook to stay engaged in our continued growth and collaboration
We hope that you enjoy the fresh look and feel of our updated new website.
Hangzhou Tigermed Consulting Co., Ltd(stock code: 300347)is a leading Contract Research Organization (CRO) in China dedicated to provide full comprehensive services and solutions for clinical research and development. Since inception in 2004, Tigermed has always embraced state-of-the-art technologies and has engaged in partnerships to accelerate medical product development with costs efficiency and high quality.
Headquartered in Hangzhou, Tigermed operates 46 subsidiaries and 123 offices across China, and 14 overseas offices in US, Switzerland, Korea, Australia, Japan, Malaysia, Singapore , India, Canada and Romania with over 5,000 full time employees. Tigermed has serviced more than 650 local and global clients in the conduct of over 2,000 clinical trials. Tigermed is recognized as “The Innovative CRO” in China, owning to our involvement of over 310 innovative drug projects.
Website: http://www.tigermed.net
Email: bd@tigermedgrp.com
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.